17.11

2.64% 0.44

After Hours: 17.07 -0.04 -0.23%

Novavax Inc (NVAX)

Overview News Price History Option Chain Financials Why NVAX Down? Discussions Forecast Stock Split

Novavax Inc stock is traded at $17.11, with a volume of 7.08M. It is up +2.64% in the last 24 hours and up +30.51% over the past month. Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Previous Close:

$16.67

Open:

$17.04

24h Volume:

7.08M

Market Cap:

$2.52B

Revenue:

$793.74M

Net Income/Loss:

$-398.71M

P/E Ratio:

-2.3567

EPS:

-7.26

Net Cash Flow:

$-514.43M

1W Performance:

+23.54%

1M Performance:

+30.51%

6M Performance:

+321.43%

1Y Performance:

+108.15%

1D Range:

$16.82

$17.81

52W Range:

$3.5324

$23.86

Novavax Inc Stock (NVAX) Company Profile

Name

Novavax Inc

Sector

Healthcare (1186)

Industry

Biotechnology (681)

Phone

240-268-2000

Address

700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD

Employee

1,992

Twitter

@novavax

Next Earnings Date

2024-08-06

Latest SEC Filings

NVAX's Discussions on Twitter

Novavax Inc Stock (NVAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-09-23	Upgrade	B. Riley Securities	Neutral → Buy
Apr-20-23	Downgrade	TD Cowen	Outperform → Market Perform
Mar-01-23	Downgrade	B. Riley Securities	Buy → Neutral
Jan-09-23	Reiterated	B. Riley Securities	Buy
Dec-30-22	Reiterated	H.C. Wainwright	Buy
Dec-02-22	Initiated	Jefferies	Hold
Sep-22-22	Downgrade	JP Morgan	Neutral → Underweight
May-20-22	Initiated	BofA Securities	Underperform
Feb-23-22	Reiterated	B. Riley Securities	Buy
Feb-22-22	Resumed	Jefferies	Buy
Jan-21-22	Initiated	Cowen	Outperform
May-12-21	Downgrade	JP Morgan	Overweight → Neutral
Dec-14-20	Initiated	Jefferies	Buy
Aug-06-20	Reiterated	H.C. Wainwright	Buy
Aug-05-20	Upgrade	JP Morgan	Neutral → Overweight
Aug-05-20	Downgrade	Ladenburg Thalmann	Neutral → Sell
Jul-16-20	Reiterated	H.C. Wainwright	Buy
Jul-08-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Jun-29-20	Reiterated	B. Riley FBR	Buy
Jun-29-20	Reiterated	H.C. Wainwright	Buy
Jun-05-20	Upgrade	JP Morgan	Underweight → Neutral
May-28-20	Reiterated	B. Riley FBR	Buy
May-12-20	Reiterated	H.C. Wainwright	Buy
Apr-30-20	Reiterated	H.C. Wainwright	Buy
Nov-27-19	Resumed	B. Riley FBR	Buy
Aug-14-19	Reiterated	H.C. Wainwright	Buy
Feb-28-19	Downgrade	Piper Jaffray	Overweight → Underweight
Dec-18-18	Initiated	Ladenburg Thalmann	Buy
Dec-11-18	Initiated	Oppenheimer	Outperform
Nov-26-18	Upgrade	Piper Jaffray	Neutral → Overweight
Sep-21-18	Upgrade	JP Morgan	Underweight → Overweight
Mar-29-18	Upgrade	Seaport Global Securities	Neutral → Buy